Abbvie Inc. vs GE HealthCare Technologies Inc.
ABBV vs GEHC — side-by-side comparison from reported financials. ABBV leads 6, GEHC leads 4 of 10 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
GE HealthCare Technologies Inc.
GEHC · Healthcare
$65.74+2.37%Mixed
| Metric | ABBV | GEHC |
|---|---|---|
| Price | $276.43 | $65.74 |
| Market cap | $488B | $29.7B |
| Revenue (TTM) | $64.4B | $21.3B |
| Revenue growth | +1.8% | +4.0% |
| Net margin | 9.8% | 9.3% |
| Free cash flow | $18.2B | $1.58B |
| Net cash (debt) | ($56.2B) | — |
| 1-year price return | +19.8% | -11.4% |
| P/E | 77.4 | 15.0 |
| P/E vs own history (cheap-side %) | 23% | 87% |
| Dividend yield | 2.45% | 0.22% |
| Return on equity | 96% | 19% |
| Altman Z-score | 2.33 | — |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 57,000 | 54,000 |
Full résumé-style profiles: ABBV CV · GEHC CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.